UroGen Pharma (URGN) P/E (2018 - 2026)
UroGen Pharma (URGN) P/E from Dec 31, 2018 to Jul 21, 2026. The TTM UroGen Pharma (URGN) P/E is -15.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of UroGen Pharma (URGN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -15.51 | +117.86% |
| 2025 | -7.12 | -30.60% |
| 2024 | -10.26 | +179.18% |
| 2023 | -3.67 | +99.44% |
| 2022 | -1.84 | -4.08% |
| 2021 | -1.92 | -37.23% |
| 2020 | -3.06 | -53.91% |
| 2019 | -6.64 | -77.45% |
| 2018 | -29.44 | N/A |
Comparison UroGen Pharma (URGN) P/E with competitors
UroGen Pharma (URGN) P/E is -15.51.